INTERNATIONAL PATENT: PFIZER INC. FILES APPLICATION FOR "PYRROLIDINE-BASED GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE RECEPTOR ANTAGONISTS AND USES THEREOF"

GENEVA, Nov. 3 -- PFIZER INC. (66 Hudson Boulevard EastNew York, New York 10001-2192) filed a patent application (PCT/IB2025/054154) for "PYRROLIDINE-BASED GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE RECEPTOR ANTAGONISTS AND USES THEREOF" on Apr 21, 2025. With publication no. WO/2025/224599, the details related to the patent application was published on Oct 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): FILIPSKI, Kevin James (c/o Pfizer Inc.610 Main StreetCambridge, Massachusetts 02139), LEE, Katarzyna Natalia (c/o Pfizer Inc.445 Eastern Point Road, Building 98Groton, Connecticut 06340...